drawing first blood FLT3 Inhibitors in Older Patients with AML
clinical news
VOLUME 02 | NUMBER 07 | JULY 2016
2016 WINNER FOR GENERAL EXCELLENCE
Around the Network
AMERICAN SOCIETY OF HEMATOLOGY ( ASH ) HEADQUARTERS 2021 L Street NW , Suite 900 Washington , DC 20036 www . hematology . org Tel : 202-776-0544
EDITOR-IN-CHIEF
Mikkael Sekeres , MD , MS
Vice-Chair for Clinical Research Director , Leukemia Program Cleveland Clinic , Taussig Cancer Institute Cleveland , OH
ASSOCIATE EDITORS
Beth Faiman , CNP , PhD Cleveland Clinic Cleveland , OH
Alice Ma , MD University of North Carolina School of Medicine Chapel Hill , NC
David Steensma , MD Dana-Farber Cancer Institute Boston , MA
Keith Stewart , MBChB , MBA Mayo Clinic Scottsdale , AZ
IN THIS ISSUE
How Do You Rank ?
Online physician-rating websites have been around for more than a decade , but many physicians and patients still have questions about how to use them . We spoke with clinicians about how reviews could help – or hurt – physicians ’ practices .
50
drawing first blood FLT3 Inhibitors in Older Patients with AML
Richard M . Stone , MD , and Selina M . Luger , MD , debate whether these drugs should be considered standard treatment for older patients with FLT3-mutated acute myeloid leukemia .
53
clinical news
27 Daratumumab Monotherapy Is Safe , Effective in Heavily Pretreated Multiple Myeloma
33 CLL-IPI : A New International Staging System for Chronic Lymphocytic Leukemia
42 On Location : 2016 ASCO Annual Meeting
PUBLISHER American Medical Communications ( AMC )
EDITORIAL
MANAGING EDITORS Ariel Jones-DeMaio , AMC Karen Learner , ASH
ASSOCIATE MANAGING EDITOR Kerri Fitzgerald , AMC
ART DIRECTOR Ari Mihos
ASSISTANT ART DIRECTORS Charlene DePrizio John Salesi
DIGITAL PROJECTS MANAGER Chris Gedikli
ADVERTISING
ACCOUNT MANAGER Nick Luciano nluciano @ americanmedicalcomm . com
Gene Conselyea gconselyea @ americanmedicalcomm . com
Recruitment advertising orders can be sent to :
DIRECTOR , RECRUITMENT CLASSIFIEDS Lauren Morgan lmorgan @ americanmedicalcomm . com
ASHCLINICALNEWS . ORG
We were on site at the 2016 ASCO Annual Meeting last month reporting on the late-breaking research and practice-changing science in malignant hematology presented at the meeting .
Check out our On Location section on page 42 for highlights from the meeting , and visit the “ On Location ” section of our website for our complete coverage , including exclusive content available only online : ashclinialnews . org / on-location .
You can also hear from the presenters and experts we spoke with at the meeting by visiting our “ Multimedia ” section : ashclinicalnews . org / ashvideo-cat / non-ash-meetings .
@ ASHCLINICALNEWS
What did you think the biggest hematology stories out of # ASCO16 were ? Tweet us at @ ASHClinicalNews to let us know .
And don ’ t forget to sign up to receive our e-newsletters to have the latest updates from ASH Clinical News delivered to your inbox : ashclinicalnews . org / enewsletter-sign-up .
Visit us at ashclinicalnews . org Follow us on Twitter @ ASHClinicalNews
© 2016 by the American Society of Hematology . All materials contained in this newsletter are protected by copyright laws and may not be used , reproduced , or otherwise exploited in any manner without the express prior written permission of ASH Clinical News . Any third-party materials communicated to ASH Clinical News become its copyrighted property and may be used , reproduced , or otherwise exploited by ASH Clinical News .
Subscription inquiries should be sent to : cwittholt @ americanmedicalcomm . com All correspondence for the American Society of Hematology should be sent to : American Society of Hematology , 2021 L Street NW , Suite 900 , Washington DC 20036 .
Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor . Statements , editorials , or opinions expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated . No responsibility is assumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability , negligence or otherwise or from any use or operation of any methods , products , instructions or ideas contained in the material herein .
Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical ( medical ) standards , inclusion in this publication does not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer .
About the American Society of Hematology The American Society of Hematology ( ASH ) is the world ’ s largest professional society concerned with the causes and treatments of blood disorders . The mission of the Society is to further the understanding , diagnosis , treatment , and prevention of disorders affecting the blood , bone marrow , and the immunologic , hemostatic and vascular systems , by promoting research , clinical care , education , training , and advocacy in hematology .
ASH Clinical News ( ISSN 2375-8120 ) is published once per month by American Medical Communications , 630 Madison Avenue , 2nd Floor , Manalapan , NJ 07726 . Periodicals postage is pending / paid at Manalapan , NJ and additional mailing offices . POSTMASTER : Send address changes to American Medical Communications , 630 Madison Avenue , 2nd Floor , Manalapan , NJ 07726 . © Copyright , 2016 .
ASHClinicalNews . org ASH Clinical News
7